Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12611001079932
Ethics application status
Approved
Date submitted
17/10/2011
Date registered
18/10/2011
Date last updated
16/06/2016
Type of registration
Prospectively registered
Titles & IDs
Public title
SCIPA (Spinal Cord Injury and Physical Activity) Switch-On - Electrical Stimulation : Acute Care
Query!
Scientific title
Functional electrical stimulation (FES)-assisted cycling versus passive cycling following spinal cord injury: Change in muscle cross-sectional are of thigh and calf post-intervention compared with baseline post spinal cord injury.
Query!
Secondary ID [1]
273228
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
SCIPA Switch-On
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Spinal Cord Injury
278982
0
Query!
Condition category
Condition code
Injuries and Accidents
279158
279158
0
0
Query!
Other injuries and accidents
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Group A: FES Cycling Group
Participants assigned to this group will undertake up to 60 minutes (excluding preparation time) of leg cycling 4 days/week for 12 weeks using a Hasomed RehaStim FES Unit attached to a MOTOmed cycle at a pedal cadence between 25-50 rev/min. This can be undertaken as a single session or split into two sessions per day, depending on the participant’s performance and the availability of staff. Surface electrodes will be applied to gluteal, quadriceps, and hamstrings muscles (not calves). Stimulation intensity will be gradually increased to a maximum of 140 mA, pulse width of 0.3 – 0.5ms and frequency of 35Hz and this will be sufficient to induce vigorous muscle contractions (Fornusek & Davis, 2008). Participants will exercise at the maximal power output possible at their level of recovery. Therapists will evaluate the degree of muscle contraction, power output and fatigue, and adjust parameters appropriately to maximise time, intensity, and power of training with a principle of overloading the muscle. When fatigue occurs, cycling can be stopped and then re-commenced after a 5 min break if muscle contraction can be elicited again. For participants with some degree of volitional muscle activity, the settings will be adjusted to ensure that resistance is maintained.
While patients are confined to bed, the MOTOmed Letto cycle will be attached to the end of the bed and patients will cycle whilst supine. The use of a similar cycle to exercise critically ill patients in ICU has resulted in no adverse events (Burtin et al. 2009). Once mobilised, patients may use an upright RT300 or MOTOmed Viva cycle attached to their wheelchair.
Query!
Intervention code [1]
269550
0
Rehabilitation
Query!
Intervention code [2]
269551
0
Treatment: Devices
Query!
Comparator / control treatment
Group B: Passive Cycling Group
Participants allocated to this group will undertake up to 60 minutes (excluding preparation time) passive cycling 4 days/week at identical pedal cadence to Group A. This can be undertaken as a single session or split into two sessions per day, depending on the participant’s performance and the availability of staff. Cycling while the participant is confined to bed will be with the MOTOmed Letto device and, once mobilised into a wheelchair, may use the RT300 or MOTOmed Viva cycle but without FES-evoked contractions.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
279800
0
Change in muscle cross-sectional area of thigh and calf post-intervention (3 months) compared to baseline.
This will be measured by MRI and DEXA scans as well as body measurements (skin folds and leg volumes).
Query!
Assessment method [1]
279800
0
Query!
Timepoint [1]
279800
0
After 12 weeks of treatment compared to baseline.
Query!
Secondary outcome [1]
294471
0
Changes in ASIA Impairtment Scale (AIS) motor and sensory scores post-intervention (3 months) compared to baseline.
Note: ASIA = American Spinal Cord Association
This will be measured by completing an ASIA assessment.
Query!
Assessment method [1]
294471
0
Query!
Timepoint [1]
294471
0
After 12 weeks of treatment compared to baseline.
Query!
Secondary outcome [2]
294472
0
Changes in intramuscular fat post-intervention (3 months) compared to baseline.
This will be measured by DEXA scans as well as body measurements (skin folds and leg volumes).
Query!
Assessment method [2]
294472
0
Query!
Timepoint [2]
294472
0
12 weeks of treatment compared to baseline.
Query!
Secondary outcome [3]
294473
0
Changes in lean muscle mass post-intervention (3 months) compared to baseline.
This will be measured by DEXA scans as well as body measurements (skin folds and leg volumes).
Query!
Assessment method [3]
294473
0
Query!
Timepoint [3]
294473
0
After 12 weeks of treatment compared to baseline.
Query!
Secondary outcome [4]
294474
0
Changes in total fat mass post-intervention (3 months) compared to baseline.
This will be measured by DEXA scans as well as body measurements (skin folds and leg volumes).
Query!
Assessment method [4]
294474
0
Query!
Timepoint [4]
294474
0
After 12 weeks of treatment compared to baseline.
Query!
Secondary outcome [5]
294475
0
Changes in leg volumes post-intervention (3 months) compared to baseline.
This will be measured by body measurements (skin folds and leg volumes).
Query!
Assessment method [5]
294475
0
Query!
Timepoint [5]
294475
0
After 12 weeks of treatment compared to baseline.
Query!
Eligibility
Key inclusion criteria
Participants will be included if they:
a) Have sustained a complete (AIS A) or incomplete SCI (AIS B, C) above T12 no more than 3 weeks previously
b) Have undergone internal fixation of spinal fracture or whose fracture is considered sufficiently stable
c) Are medically stable
d) Are able to provide informed consent
e) Have medical and surgical clearance to participate in the study
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Participants will be excluded if they:
a) Are under 18 years of age
b) Are classified as AIS D at baseline
c) Are in a halo or receiving any other traction
d) Are in ICU
e) Have pressure ulcers
f) Have peripheral nerve lesion
g) Have long bone or pelvic fracture
h) Have lower limb amputation
i) Have had previous FES to lower limbs
j) Are on a ventolator
k) Have metabolic bone disease, including lytic or renal bone disease, or senile osteoporosis
l) Have had exposure to drugs that affect bone metabolism (amino-bisphosphonate, high dose glucocorticoids, cyclosporine, anti-epileptic drugs [AEDs])
m) Have any contraindications to FES or MRI (cardiac pacemaker, epilepsy, pregnancy, skin grafts, lower limb injuries)
n) Have any other contraindications to participating in exercise programs, or outcome assessments, as advised by the treating physician (e.g. autonomic hyper-reflexia, suboptimal oxygen saturation)
o) English language competency insufficient to understand research procedures and provide informed consent.
p) Have any other serious medical condition including malignancies, psychiatric, behavioural or drug-dependency problems, which are likely to influence the participant’s ability to cooperate or in the opinion of the study investigator would prevent adherence to the Protocol.
q) Are participating in any other therapy (including alternative therapies) or taking medications (including herbal preparations) that are not considered to be standard care as per the protocol.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants will participate in pre-screening, then screening and baseline visits prior to randomisation. Eligible participants will be randomised to one of two groups: 1. Group A - FES-Cycling or 2. Group B - Passive-Cycling. Randomisation will be stratified by injury status (ASIA A, B or C) and co-ordinated by a central randomisation unit. Upon completion of all screening and baseline assessments and suitability checks, a participant eligibility checklist will be completed by the Site Coordinator and signed by the Principal Investigator. This checklist will be sent to the central randomisation unit who will notify the Site Coordinator of treatment assignment. This will not be disclosed to the Blinded Assessors.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation by using a randomization table created by a computer software (i.e. computerised sequence generation)
Participants will be stratefied by injury status (ASIA A, B or C)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/02/2012
Query!
Actual
26/11/2012
Query!
Date of last participant enrolment
Anticipated
31/05/2014
Query!
Actual
29/05/2014
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
50
Query!
Accrual to date
Query!
Final
24
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment postcode(s) [1]
4649
0
3084
Query!
Recruitment postcode(s) [2]
4650
0
4102
Query!
Recruitment postcode(s) [3]
4651
0
6008
Query!
Recruitment outside Australia
Country [1]
3911
0
New Zealand
Query!
State/province [1]
3911
0
Christchurch
Query!
Funding & Sponsors
Funding source category [1]
270050
0
Other Collaborative groups
Query!
Name [1]
270050
0
Transport Accident Commission (TAC)
Query!
Address [1]
270050
0
Level 2, 60 Brougham Street
PO Box 2314
Geelong VIC 3220
Query!
Country [1]
270050
0
Australia
Query!
Funding source category [2]
270051
0
Government body
Query!
Name [2]
270051
0
National Health and Medical Research Council (NH&MRC)
Query!
Address [2]
270051
0
GPO Box 1421
Canberra ACT 2601
Query!
Country [2]
270051
0
Australia
Query!
Primary sponsor type
University
Query!
Name
The University of Melbourne
Query!
Address
The University of Melbourne, Parkville, VIC 3101
Query!
Country
Australia
Query!
Secondary sponsor category [1]
269019
0
None
Query!
Name [1]
269019
0
Query!
Address [1]
269019
0
Query!
Country [1]
269019
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
272009
0
Austin Health Research Ethics Committee
Query!
Ethics committee address [1]
272009
0
Henry Buck Building Austin Hospital 145 Studley Road Heidelberg Victoria, 3084
Query!
Ethics committee country [1]
272009
0
Australia
Query!
Date submitted for ethics approval [1]
272009
0
27/10/2011
Query!
Approval date [1]
272009
0
20/02/2012
Query!
Ethics approval number [1]
272009
0
H2012/04476
Query!
Summary
Brief summary
This study is a multi-centre, assessor-blinded, randomised controlled Phase I trial in people with spinal cord injury. This study is funded by a grant from the Victorian Neurotrauma Initiative. A total of 50 participants with complete or incomplete spinal cord injury will be randomised into two groups: an experimental group and a control group. The control group will undertake a passive cycling program using a bed bike while in the acute ward and an upright bike once they progress to rehabilitation. The experimental group will undertake a FES-assisted cycling program using a bed bike while in the acute ward and an upright bike once they progress to rehabilitation. Both programs will consist of 60 minutes of training 4 times per week for 12 weeks. Training will commence once the participant is considered medically stable (a minimum 5 days post-injury, maximum 4 weeks post-injury). The main objective of the study is to determine the relative effectiveness of FES-assisted cycling compared to passive cycling on muscle cross-sectional area of thigh and calf. The total study duration is 2 years, including an 18month recruitment period, a 12 week treatment period and post-intervention assessments (within a week of last treatment).
Query!
Trial website
www.scipa.unimelb.edu.au
Query!
Trial related presentations / publications
MP Galea,, SA Dunlop, R Marshall, J Clark, L Churilov. Early exercise after spinal cord injury (‘Switch-On’): study protocol for a randomised controlled trial. Trials (2015) 16:7 Results publication is pending submission.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
33274
0
Prof Mary Galea
Query!
Address
33274
0
Department of Medicine (Royal Melbourne Hospital)
The University of Melbourne
Royal Park Campus
34-54 Poplar Road
Parkville, Victoria, 3052
Australia
Query!
Country
33274
0
Australia
Query!
Phone
33274
0
+61 3 8387 2017
Query!
Fax
33274
0
Query!
Email
33274
0
[email protected]
Query!
Contact person for public queries
Name
16521
0
Melanie Hurley
Query!
Address
16521
0
Neuroscience Trials Australia (SCIPA / University of Melbourne)
(a business unit within the Florey Institute of Neuroscience and Mental Health) Melbourne Brain Centre - Austin Campus
245 Burgundy Street
Heidelberg VIC 3084
Query!
Country
16521
0
Australia
Query!
Phone
16521
0
+61 3 9035 7235
Query!
Fax
16521
0
+61 3 9496 2881
Query!
Email
16521
0
[email protected]
Query!
Contact person for scientific queries
Name
7449
0
Prof Mary Galea
Query!
Address
7449
0
Department of Medicine (Royal Melbourne Hospital)
The University of Melbourne
Royal Park Campus
34-54 Poplar Road
Parkville, Victoria, 3052
Australia
Query!
Country
7449
0
Australia
Query!
Phone
7449
0
+61 3 8387 2017
Query!
Fax
7449
0
Query!
Email
7449
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Early exercise after spinal cord injury ('Switch-On'): Study protocol for a randomised controlled trial.
2015
https://dx.doi.org/10.1186/1745-6215-16-7
Embase
SCIPA Switch-On: A Randomized Controlled Trial Investigating the Efficacy and Safety of Functional Electrical Stimulation-Assisted Cycling and Passive Cycling Initiated Early after Traumatic Spinal Cord Injury.
2017
https://dx.doi.org/10.1177/1545968317697035
Embase
Factors influencing thigh muscle volume change with cycling exercises in acute spinal cord injury-a secondary analysis of a randomized controlled trial.
2022
https://dx.doi.org/10.1080/10790268.2020.1815480
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF